# Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice

> **NCT01579955** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 321 (actual)

## Conditions studied

- Congenital Bleeding Disorder
- Haemophilia A With Inhibitors
- Haemophilia B With Inhibitors

## Interventions

- **DRUG:** eptacog alfa (activated)

## Key facts

- **NCT ID:** NCT01579955
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1999-03-10
- **Primary completion:** 2010-03-09
- **Final completion:** 2010-03-09
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01579955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01579955, "Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01579955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*